Cargando…

Biomarker analysis to predict the pathological response to neoadjuvant chemotherapy in locally advanced gastric cancer: An exploratory biomarker study of COMPASS, a randomized phase II trial

Background: The findings of COMPASS, a randomized phase II study, suggested that the regimens and courses of neoadjuvant chemotherapy (NAC) for locally advanced gastric cancer (GC) did not affect the pathological response. However, pathological complete response was achieved in 10% patients who rece...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oshima, Takashi, Yoshikawa, Takaki, Miyagi, Yohei, Morita, Satoshi, Yamamoto, Michio, Tanabe, Kazuaki, Nishikawa, Kazuhiro, Ito, Yuichi, Matsui, Takanori, Kimura, Yutaka, Yokose, Tomoyuki, Hiroshima, Yukihiko, Aoyama, Toru, Hayashi, Tsutomu, Ogata, Takashi, Cho, Haruhiko, Rino, Yasushi, Masuda, Munetaka, Tsuburaya, Akira, Sakamoto, Junichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7392622/ https://www.ncbi.nlm.nih.gov/pubmed/32774771 http://dx.doi.org/10.18632/oncotarget.27658

Ejemplares similares

Methylene blue-assisted technique for harvesting lymph nodes after radical surgery for gastric cancer: a prospective randomized phase III study
por: Aoyama, Toru, et al.
Publicado: (2014)

Identification of a Biomarker Combination for Survival Stratification in pStage II/III Gastric Cancer after Curative Resection
por: Hashimoto, Itaru, et al.
Publicado: (2022)

High gamma-glutamyl hydrolase and low folylpolyglutamate synthetase expression as prognostic biomarkers in patients with locally advanced gastric cancer who were administrated postoperative adjuvant chemotherapy with S-1
por: Maezawa, Yukio, et al.
Publicado: (2019)

Gastric cancer biomarker analysis in patients treated with different adjuvant chemotherapy regimens within SAMIT, a phase III randomized controlled trial
por: Oshima, Takashi, et al.
Publicado: (2022)

Prediction of postoperative inflammatory complications after esophageal cancer surgery based on early changes in the C-reactive protein level in patients who received perioperative steroid therapy and enhanced recovery after surgery care: a retrospective analysis
por: Kano, Kazuki, et al.
Publicado: (2017)

A Methylene Blue–assisted Technique for Harvesting Lymph Nodes After Radical Surgery for Gastric Cancer: A Prospective, Randomized, Controlled Study
por: Aoyama, Toru, et al.
Publicado: (2015)

Feasibility of enhanced recovery after surgery in gastric surgery: a retrospective study
por: Yamada, Takanobu, et al.
Publicado: (2014)

The postoperative lean body mass loss at one month leads to a poor survival in patients with locally advanced gastric cancer
por: Aoyama, Toru, et al.
Publicado: (2019)

Identification of a high‐risk subtype of intestinal‐type Japanese gastric cancer by quantitative measurement of the luminal tumor proportion
por: Aoyama, Toru, et al.
Publicado: (2018)

Impact of the Age-adjusted Charlson comorbidity index on the short- and long-term outcomes of patients undergoing curative gastrectomy for gastric cancer
por: Maezawa, Yukio, et al.
Publicado: (2019)

Evaluation of short-term outcomes of laparoscopic-assisted surgery for colorectal cancer in elderly patients aged over 75 years old: a multi-institutional study (YSURG1401)
por: Kazama, Keisuke, et al.
Publicado: (2017)

Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine
por: Aoyama, Toru, et al.
Publicado: (2017)

Risk factors analysis and stratification for microscopically positive resection margin in gastric cancer patients
por: Kumazu, Yuta, et al.
Publicado: (2020)

Visualization of blood supply route to the reconstructed stomach by indocyanine green fluorescence imaging during esophagectomy
por: Rino, Yasushi, et al.
Publicado: (2014)

Using NU-KNIT® for hemostasis around recurrent laryngeal nerve during transthoracic esophagectomy with lymphadenectomy for esophageal cancer
por: Rino, Yasushi, et al.
Publicado: (2014)

Predictive role of human equilibrative nucleoside transporter 1 in patients with pancreatic cancer treated by curative resection and gemcitabine-only adjuvant chemotherapy
por: Aoyama, Toru, et al.
Publicado: (2017)

Successful Conversion Surgery for Stage IV Gastric Cancer after Nivolumab Monotherapy as Third-Line Chemotherapy
por: Watanabe, Hayato, et al.
Publicado: (2021)

Signet-ring Cell Carcinoma Component as an Indicator of Anaplastic Lymphoma Kinase Mutations in Colorectal Cancer
por: Nukada, Suguru, et al.
Publicado: (2021)

Clinical implications of dihydropyrimidine dehydrogenase expression in patients with pancreatic cancer who undergo curative resection with S-1 adjuvant chemotherapy
por: Murakawa, Masaaki, et al.
Publicado: (2017)

Detection of EGFR mutation of pulmonary adenocarcinoma in sputum using droplet digital PCR
por: Isaka, Tetsuya, et al.
Publicado: (2021)

Phase II study on the combination of irinotecan plus cisplatin as a second-line therapy in patients with advanced or recurrent gastric cancer
por: RINO, YASUSHI, et al.
Publicado: (2013)

Comprehensive biomarker analyses identifies HER2, EGFR, MET RNA expression and thymidylate synthase 5'UTR SNP as predictors of benefit from S-1 adjuvant chemotherapy in Japanese patients with stage II/III gastric cancer
por: Yoshikawa, Takaki, et al.
Publicado: (2019)

Expression of enhancer of zeste homolog 2 correlates with survival outcome in patients with metastatic breast cancer: exploratory study using primary and paired metastatic lesions
por: Inari, Hitoshi, et al.
Publicado: (2017)

Lung adenocarcinoma in a patient with a cis EGFR L858R‐K860I doublet mutation identified using NGS‐based profiling test: Negative diagnosis on initial companion test and successful treatment with osimertinib
por: Onozawa, Hiroto, et al.
Publicado: (2020)

The Effect of Intraoperative Use of High-Dose Remifentanil on Postoperative Insulin Resistance and Muscle Protein Catabolism: A Randomized Controlled Study
por: Taniguchi, Hideki, et al.
Publicado: (2013)

Primary placement technique of jejunostomy using the entristar™ skin-level gastrostomy tube in patients with esophageal cancer
por: Rino, Yasushi, et al.
Publicado: (2011)

Machine-learning model derived gene signature predictive of paclitaxel survival benefit in gastric cancer: results from the randomised phase III SAMIT trial
por: Sundar, Raghav, et al.
Publicado: (2022)

Impact of the epidermal growth factor receptor mutation status on the prognosis of recurrent adenocarcinoma of the lung after curative surgery
por: Isaka, Tetsuya, et al.
Publicado: (2018)

Origin of diverse phosphorylation patterns in the ERBB system
por: Okada, Takashi, et al.
Publicado: (2022)

Effects of perioperative Eicosapentaenoic acid-enriched oral nutritional supplement on lean body mass after total gastrectomy for gastric cancer
por: Aoyama, Toru, et al.
Publicado: (2019)

Short-term results of a phase II study of preoperative docetaxel/cisplatin/S-1 therapy for locally advanced gastric cancer
por: Tsuchida, Kazuhito, et al.
Publicado: (2020)

The clinical impact of Hangeshashinto (TJ-14) in the treatment of chemotherapy-induced oral mucositis in gastric cancer and colorectal cancer: Analyses of pooled data from two phase II randomized clinical trials (HANGESHA-G and HANGESHA-C)
por: Nishikawa, Kazuhiro, et al.
Publicado: (2018)

Double-blind, placebo-controlled, randomized phase II study of TJ-14 (hangeshashinto) for gastric cancer chemotherapy-induced oral mucositis
por: Aoyama, Toru, et al.
Publicado: (2014)

A case of undifferentiated pleomorphic sarcoma of the breast with lung and bone metastases
por: Yamazaki, Haruhiko, et al.
Publicado: (2018)

Epigenetic silencing of checkpoint with fork-head associated and ring finger gene expression in esophageal cancer
por: SUZUKI, YOSHIHIRO, et al.
Publicado: (2014)

Primary results of a randomized two‐by‐two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of cisplatin/S‐1 and docetaxel/cisplatin/S‐1 as neoadjuvant chemotherapy for advanced gastric cancer
por: Hayashi, Tsutomu, et al.
Publicado: (2020)

A Phase II Study of S-1 Monotherapy as a First-line Combination Therapy of S-1 Plus Cisplatin as a Second-line Therapy, and Weekly Paclitaxel Monotherapy as a Third-line Therapy in Patients with Advanced Gastric Carcinoma: A Second Report
por: Rino, Yasushi, et al.
Publicado: (2010)

Clinical Effects of the Neutrophil-to-Lymphocyte Ratio/Serum Albumin Ratio in Patients with Gastric Cancer after Gastrectomy
por: Onuma, Shizune, et al.
Publicado: (2023)

Randomized phase II study of TJ-54 (Yokukansan) for postoperative delirium in gastrointestinal and lung malignancy patients
por: Sugano, Nobuhiro, et al.
Publicado: (2017)

Rapidly progressed neuroendocrine carcinoma in the extrahepatic bile duct: a case report and review of the literature
por: Kamiya, Mariko, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_mfq1o47lq1pcpbj7061efrdjts